Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats
- PMID: 17332430
- DOI: 10.1161/01.RES.0000261658.12024.18
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats
Abstract
Vascular remodeling, rather than vasoconstriction, is believed to account for high vascular resistance in severe pulmonary arterial hypertension (PAH). We have found previously that acute Rho kinase inhibition nearly normalizes PAH in chronically hypoxic rats that have no occlusive neointimal lesions. Here we examined whether Rho kinase-mediated vasoconstriction was also important in a rat model of severe occlusive PAH. Adult rats were exposed to chronic hypoxia ( approximately 10% O(2)) after subcutaneous injection of the vascular endothelial growth factor receptor inhibitor SUGEN 5416. Hemodynamic measurements were made in anesthetized rats after 2 weeks of hypoxia (early group) and 3 weeks of hypoxia plus 2 weeks of normoxia (late group). Both groups developed PAH, with greater severity in the late group. In the early group, intravenous fasudil was more effective than intravenous bradykinin, inhaled NO, or intravenous iloprost in reducing right ventricular systolic pressure. Despite more occlusive vascular lesions, fasudil also markedly reduced right ventricular systolic pressure in late-stage rats. Blood-perfused lungs from late-stage rats showed spontaneous vasoconstriction, which was reversed partially by the endothelin A receptor blocker BQ123 and completely by fasudil or Y-27632. Phosphorylation of MYPT1, a downstream target of Rho kinase, was increased in lungs from both groups of rats, and fasudil (intravenous) reversed the increased phosphorylation in the late group. Thus, in addition to structural occlusion, Rho kinase-mediated vasoconstriction is an important component of severe PAH in SUGEN 5416/hypoxia-exposed rats, and PAH can be significantly reduced in the setting of a severely remodeled lung circulation if an unconventional vasodilator is used.
Similar articles
-
Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.Am J Respir Crit Care Med. 2005 Mar 1;171(5):494-9. doi: 10.1164/rccm.200405-637OC. Epub 2004 Nov 24. Am J Respir Crit Care Med. 2005. PMID: 15563635
-
Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.Chin Med J (Engl). 2007 Jan 5;120(1):22-9. Chin Med J (Engl). 2007. PMID: 17254483
-
Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.J Appl Physiol (1985). 2006 Mar;100(3):996-1002. doi: 10.1152/japplphysiol.01028.2005. Epub 2005 Dec 1. J Appl Physiol (1985). 2006. PMID: 16322374
-
Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors.Tohoku J Exp Med. 2007 Apr;211(4):309-20. doi: 10.1620/tjem.211.309. Tohoku J Exp Med. 2007. PMID: 17409670 Review.
-
Hypoxia and Rho/Rho-kinase signaling. Lung development versus hypoxic pulmonary hypertension.Adv Exp Med Biol. 2003;543:127-37. Adv Exp Med Biol. 2003. PMID: 14713118 Review.
Cited by
-
Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):241-283. doi: 10.1089/jamp.2024.0016. J Aerosol Med Pulm Drug Deliv. 2024. PMID: 39388691 Review.
-
Regulation and function of miR-214 in pulmonary arterial hypertension.Pulm Circ. 2016 Mar;6(1):109-17. doi: 10.1086/685079. Pulm Circ. 2016. PMID: 27162619 Free PMC article.
-
Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension.Mol Ther Methods Clin Dev. 2016 Jul 6;3:16044. doi: 10.1038/mtm.2016.44. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27419193 Free PMC article.
-
Pathogenic mechanisms of pulmonary arterial hypertension.J Mol Cell Cardiol. 2008 Jan;44(1):14-30. doi: 10.1016/j.yjmcc.2007.09.006. Epub 2007 Sep 20. J Mol Cell Cardiol. 2008. PMID: 17950310 Free PMC article. Review.
-
Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension.Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L639-L652. doi: 10.1152/ajplung.00396.2018. Epub 2019 Aug 28. Am J Physiol Lung Cell Mol Physiol. 2019. PMID: 31461316 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical